Ginkgo Bioworks (DNA) Q3 2024 Earnings
DNA·Reported November 12, 2024·After market close
Ginkgo Bioworks reported Q3 2024 revenue of $89.0M, beat analyst consensus of $44.4M by $44.6M. Diluted EPS came in at $-1.08, beat the $-2.40 consensus by $1.32.
Revenue
$89.0Mbeat by $44.6M
Consensus: $44.4MDiluted EPS
$-1.08beat by $1.32
Consensus: $-2.40
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Ginkgo Bioworks's Q3 2024 earnings report.
Ginkgo Bioworks (DNA) reported Q3 2024 earnings on November 12, 2024 after market close.
Ginkgo Bioworks reported revenue of $89.0M and diluted EPS of $-1.08 for Q3 2024.
Revenue beat the consensus estimate of $44.4M by $44.6M. EPS beat the consensus estimate of $-2.40 by $1.32.
You can read the 10-Q periodic report (0001628280-24-047284) directly on SEC EDGAR. The filing index links above go to sec.gov.